Table 2.
Clinicopathological parameters | Number of Cases (%) | RQ (Mean±SE) | p-value |
---|---|---|---|
Patients (n) | 30 (100 %) | ||
Age group | |||
≤50 years | 14 (47%) | 6.69± 1.04 | 0.002* |
>50 years | 16 (53%) | 2.90± 0.46 | |
Sex | |||
Male | 19 (63%) | 5.76± 0.94 | 0.255 |
Female | 11 (37%) | 4.14± 0.82 | |
Tumor Location | |||
Proximal | 16 (53%) | 6.83± 0.99 | 0.015* |
Distal | 14 (47%) | 3.61± 0.77 | |
TNM stage | 0.286 | ||
I + II | 21 (70%) | 5.77± 0.94 | |
III | 9 (30%) | 4.12± 0.68 | |
Lymph node metastasis | 0.286 | ||
Yes | 9 (30%) | 4.12± 0.68 | |
No | 21 (70%) | 5.77 ± 0.94 | |
Histopathological Type | 0.549 | ||
Adenocarcinoma | 22 (73%) | 5.61± 0.95 | |
Other Types | 8 (27%) | 4.60 ± 0.83 | 0.86 |
Histopathological grade | 28 (93%) | 5.16± 0.74 | |
Good + Moderate | 2 (7%) | 5.67± 0.61 | |
Poor |